Delcath Systems, Inc. (DCTH) Achieves Key Milestone with J.W. Goethe Hospital Partnership
Delcath Systems Inc., a development stage specialty pharmaceutical and medical device company focused on oncology, has entered into an initial launch and training agreement with Johann Wolfgang Goethe University Hospital (J.W. Goethe), representing a significant step in Delcath’s progress toward EU market expansion. J.W. Goethe is a premier European cancer treatment and research center located in Frankfurt, Germany. Per the agreement, Delcath will provide J.W. Goethe with logistics and clinical training support for the Delcath Hepatic CHEMOSAT® delivery system. "Our team is excited to bring use of the CHEMOSAT system to Germany. Clinical research suggests that chemosaturation therapy using the…